FSD Pharma rises on 1.9 mln share buyback plan

Quantum Biopharma

13/01/2023 16:18

** U.S.-listed shares of Canada-based drug developer FSD
Pharma Inc  HUGE.O  up 8.3% at 96 cents - set for biggest
one-day pct gain in over two months 
    ** Co says its board has authorized a share buyback program
of up to 1.9 mln of its subordinate class B voting shares under
normal course issuer bid (NCIB), effective Jan. 18
    ** NCIB is a stock buyback program used by companies listed
in Canada  
    ** HUGE plans to complete the buyback over a 12-month period
expiring on Jan. 17, 2024
    ** Including session moves, HUGE shares have fallen ~8.4% in
the past 12 months
 (Reporting by Mariam E Sunny)
 ((Mariam.ESunny@thomsonreuters.com;))